Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion type Assertion NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_head.
- NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion description "[To study the molecular changes underscoring the RA-LPD, mutations of p53 and Bak gene were analyzed in RA-LPD with (MTX-LPD) or without methotrexate treatment for RA (non-MTX-LPD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_provenance.
- NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion evidence source_evidence_literature NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_provenance.
- NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion SIO_000772 16988840 NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_provenance.
- NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion wasDerivedFrom befree-20150227 NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_provenance.
- NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_assertion wasGeneratedBy ECO_0000203 NP869817.RAex2c6g001X3InVgYM6vtgIxkbVCOi5dxv87CDRUNu0k130_provenance.